One year in: Pfizer's cancer strategy

Wednesday, June 3, 2026 | 11:00 AM - 1:00 PM ET

Jeff Legos took over as Pfizer's Chief Oncology Officer with a clear mandate: turn the pharma cancer pipeline into a growth engine. One year in, the strategy is starting to come into focus — and so are the trade-offs.

We'll sit down with Legos at ASCO for a conversation on how he's thinking about the pipeline, where Pfizer is placing its biggest cancer bets, and what's coming next. Join us.

SPONSORED BY

Sponsorship opportunities are available.
Contact Meg at mestacio@endpointsnews.com to learn how you can support Endpoints at ASCO 2026.